STOCK TITAN

Medline (MDLN) HR chief has 872 shares withheld for RSU tax payment

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Medline Inc. Chief Human Resources Officer Christopher P. Shryock reported a routine tax-withholding transaction involving company stock. On the vesting of restricted stock units, 872 shares of Class A Common Stock were withheld at a value of $36.61 per share to satisfy his tax liability, as noted in the footnote. After this non-market disposition for taxes, he directly holds 11,031 shares of Medline common stock.

Positive

  • None.

Negative

  • None.
Insider Shryock Christopher P
Role Chief Human Resources Officer
Type Security Shares Price Value
Tax Withholding Class A Common Stock 872 $36.61 $32K
Holdings After Transaction: Class A Common Stock — 11,031 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares withheld for taxes 872 shares Tax-withholding disposition linked to RSU vesting
Per-share value for withholding $36.61 per share Value applied to 872 withheld shares
Shares held after transaction 11,031 shares Direct holdings after tax-withholding transaction
restricted stock units financial
"in connection with the vesting of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax-withholding disposition financial
"transaction_action: tax-withholding disposition of 872 shares"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Class A Common Stock financial
"security_title: Class A Common Stock reported in the filing"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shryock Christopher P

(Last)(First)(Middle)
C/O MEDLINE INC.
3 LAKES DRIVE

(Street)
NORTHFIELD ILLINOIS 60093

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Medline Inc. [ MDLN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Human Resources Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/15/2026F(1)872D$36.6111,031D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Reflects shares withheld to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units.
/s/ Nicole Fritz, Attorney-in-Fact06/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Medline (MDLN) executive Christopher P. Shryock report in this Form 4?

Christopher P. Shryock reported a tax-withholding disposition of Medline Class A Common Stock. 872 shares were withheld in connection with the vesting of restricted stock units to cover his related tax liability.

How many Medline (MDLN) shares were withheld for taxes in this Form 4?

The filing shows 872 Medline Class A Common Stock shares were withheld. These shares satisfied Christopher P. Shryock’s tax liability arising from the vesting of restricted stock units, rather than an open-market sale of shares.

At what value were the Medline (MDLN) shares withheld for Christopher P. Shryock?

The withheld shares are reported at $36.61 per share. This value applies to the 872 Class A Common Stock shares used to cover Christopher P. Shryock’s tax obligations from restricted stock unit vesting.

How many Medline (MDLN) shares does Christopher P. Shryock hold after this transaction?

After the tax-withholding transaction, Christopher P. Shryock directly holds 11,031 Medline Class A Common Stock shares. This figure reflects his position following the shares withheld to satisfy his restricted stock unit tax liability.

Was this Medline (MDLN) Form 4 a market sale of shares?

No, the Form 4 describes a tax-withholding disposition, not a market sale. Shares were withheld by Medline to satisfy Christopher P. Shryock’s tax liability related to vesting restricted stock units, according to the footnote disclosure.